Proceedings of the 2019 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Annual Scientific Meeting

Table 1 (abstract A65). Correlations with depression (PHQ9) and anxiety (GAD7) scores in youth with SLE

	PHQ9 score	GAD7 score
GAD7 score	0.7, p<0.0001	1.00
SLEDAI score	0.07, p=0.6	0.2, p=0.2
Steroid dose	-0.05, p=0.7	-0.1, p=0.3
Disease duration	0.06, p=0.6	0.02, p=0.9
PROMIS measures:
Worse depression	0.7, p<0.0001	0.7, p<0.0001
Worse anxiety	0.6, p<0.0001	0.8, p<0.0001
Worse fatigue	0.7, p<0.0001	0.6, p<0.0001
Stronger peer relationships	-0.3, p=0.002	-0.4, p=0.009
Lower physical functioning	0.4, p=0.0001	0.4, p=0.0004
Higher pain interference	0.5, p<0.0001	0.6, p<0.0001
Higher pain severity	0.5, p<0.0001	0.4, p=0.0003

PHQ9 (Patient Health Questionnaire-9) scores ranged from 0-27; GAD7 (Generalized Anxiety 7-Index) scores ranged from 0-21. SLEDAI (SLE Disease Activity Index 2K Modification) scores ranged from 0-20 (of a possible range 0-105). Steroid dose was current daily dose. PROMIS (Patient Reported Outcome Measurement Information System) scores were measured as T-scores, except for pain severity measured on a scale of 1-10. Spearman rho correlation coefficients shown

ISSN: 1546-0096